Hjem › Brystkreft › Illinois › Waukegan
Kliniske studier for Brystkreft i Waukegan, IL
12 studier for Brystkreft søker deltakere på steder i og rundt Waukegan (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- AMG Libertyville - Oncology, Libertyville · 8 mi unna
- Condell Memorial Hospital, Libertyville · 8 mi unna
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RekruttererFase 2
- City of Hope Chicago, Zion · 6 mi unna
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekruttererFase 1/2
- City of Hope, Chicago, Zion · 6 mi unna
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
RekruttererFase 1/2
- City of Hope® Cancer Center Chicago, Zion · 6 mi unna
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruttererFase 1
- City of Hope - Chicago, Zion · 6 mi unna
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
RekruttererFase 1/2
- City of Hope® Cancer Center Chicago, Zion · 6 mi unna
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RekruttererFase 3
- City of Hope® Cancer Center Chicago, Zion · 6 mi unna
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi unna
- AMG Libertyville - Oncology, Libertyville · 8 mi unna
- Condell Memorial Hospital, Libertyville · 8 mi unna
- og 1 flere
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekruttererFase 3
- City of Hope - Cancer Center Chicago, Zion · 6 mi unna
E-Mindfulness Approaches for Living After Breast Cancer
RekruttererFase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi unna
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi unna
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruttererFase 3
- Midwestern Regional Medical Center, Zion · 6 mi unna
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi unna
- AMG Libertyville - Oncology, Libertyville · 8 mi unna
- og 2 flere
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruttererObservasjonsstudie
- AMG Libertyville - Oncology, Libertyville · 8 mi unna
- Condell Memorial Hospital, Libertyville · 8 mi unna
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Waukegan
- Ikke-småcellet lungekreft16 studier
- Lungekreft16 studier
- Ulcerøs kolitt7 studier
- Nyrekreft (nyrecellekarcinom)7 studier
- Eggstokkreft6 studier
- Metastatisk kreft6 studier
- Plateepitelcancer i hode og hals6 studier
- Kolorektal kreft6 studier
- Prostatakreft6 studier
- Melanom5 studier
- Akut myelogen leukemi5 studier
- Crohns sykdom5 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.